Tandem Diabetes Care (TNDM) 2024年年度报告「NASDAQ」.pdf

1、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549_FORM 10-K_ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the fiscal year ended December 31,2024orTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the

2、transition period from to Commission File Number 001-36189_Tandem Diabetes Care,Inc.(Exact name of registrant as specified in its charter)_Delaware20-4327508(State or other jurisdiction of incorporation or organization)(I.R.S.Employer Identification No.)12400 High Bluff Drive92130San Diego Californi

3、a(Zip Code)(Address of principal executive offices)(858)366-6900Registrants telephone number,including area codeSecurities registered pursuant to Section 12(b)of the Act:Title of Each ClassTrading Symbol(s)Name of Each Exchange on Which RegisteredCommon Stock,par value$0.001 per shareTNDMNasdaq Glob

4、al MarketSecurities registered pursuant to Section 12(g)of the Act:_None_Indicate by check mark if the registrant is a well-known seasoned issuer,as defined in Rule 405 of the Securities Act.Yes No Indicate by check if the registrant is not required to file reports pursuant to Section 13 or Section

5、15(d)of the Act.Yes No Indicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 during the preceding 12 months(or for such shorterperiod that the registrant was required to file such reports)and(2)has been

6、 subject to such filing requirements for the past 90 days.Yes No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T(232.405 of this chapter)during thepreceding 12 months(or for such sh